CHE · Chemed Corp
$532.88
-4.29 (-0.80%)
At close · Aug 14
Market Cap
$6.96B
Shares
13.07M
Chemed Corp Earnings Call Transcripts
Every quarterly earnings call for Chemed Corp (CHE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼2.3%
$526.47M
$56.87M
'22 Q3
22-10-31
▲1%
$546.65M
$62.13M
'22 Q4
23-02-23
▲5.6%
$560.16M
$54.12M
'23 Q1
23-04-26
▲4.2%
$553.82M
$53.38M
'23 Q2
23-07-26
▲7.2%
$564.53M
$74.96M
'23 Q3
23-10-25
▲7.2%
$585.91M
$90.05M
'23 Q4
24-02-27
▲5.2%
$589.23M
$65.02M
'24 Q1
24-04-24
▲7.6%
$595.88M
$70.89M
'24 Q2
24-07-24
▲7.4%
$606.18M
$75.78M
'24 Q3
24-10-29
▲9.2%
$639.99M
$90.32M
'24 Q4
25-02-26
▲9.8%
$646.94M
$71.76M
'25 Q1
25-04-23
▲3.8%
$618.80M
$52.49M
'25 Q2
25-07-29
▲3.1%
$624.90M
$64.24M
'25 Q3
25-10-28
▼0.1%
$639.34M
$76.75M
'25 Q4
26-02-26
▲1.6%
$657.51M
$66.30M
'26 Q1
26-04-24
LATEST
▲8.8%
$673.25M
$67.70M
'26 Q2
26-07-29
Earnings call
FY26 · Q2
2026-07-29
Chemed Corp Q2 FY2026 Earnings Call
Confident tone
VITAS hospice admissions growth
Florida Medicare cap position
Roto-Rooter commercial business
Revenue
$673.25M
▲ 8.8% YoY Diluted EPS
$5.13
▲ 43.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-24
Chemed Corp Q1 FY2026 Earnings Call
Confident tone
VITAS admissions and patient mix
VITAS regulatory and fraud concerns
Florida Medicare cap position
Revenue
$657.51M
▲ 1.6% YoY Diluted EPS
$4.84
▼ 0.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Chemed Corp Q4 FY2025 Earnings Call
Positive tone
Paid vs. natural search leads
VITAS admissions mix rebalancing
Water restoration billing and collections
Revenue
$639.34M*
▼ 0.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Chemed Corp Q3 FY2025 Earnings Call
Positive tone
VITAS Medicare Cap mitigation
Lead generation mix shift
VITAS admissions and census growth
Revenue
$624.90M
▲ 3.1% YoY Diluted EPS
$4.46
▼ 10.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Chemed Corp Q2 FY2025 Earnings Call
Cautious tone
VITAS Medicare cap / Florida billing limitation
VITAS admissions and patient mix
Roto-Rooter competition and marketing
Revenue
$618.80M
▲ 3.8% YoY Diluted EPS
$3.57
▼ 23.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Chemed Corp Q1 FY2025 Earnings Call
Confident tone
VITAS operating performance and growth
Roto Rooter revenue and margin trends
Medicare cap management
Revenue
$646.94M
▲ 9.8% YoY Diluted EPS
$4.86
▲ 14.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Chemed Corp Q4 FY2024 Earnings Call
Positive tone
VITAS Healthcare operations
Medicare cap limitations
2025 financial guidance
Revenue
$639.99M*
▲ 9.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-29
Chemed Corp Q3 FY2024 Earnings Call
Balanced tone
Roto-Rooter revenue decline
VITAS Healthcare strong performance
2025 outlook and guidance
Revenue
$606.18M
▲ 7.4% YoY Diluted EPS
$5.00
▲ 1.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Chemed Corp Q2 FY2024 Earnings Call
Confident tone
Florida Market Expansion (CON)
Covenant Health Acquisition
VITAS Hospice Operating Strength
Revenue
$595.88M
▲ 7.6% YoY Diluted EPS
$4.65
▲ 32.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
Chemed Corp Q1 FY2024 Earnings Call
Positive tone
VITAS admissions and census growth
VITAS hiring and retention
Covenant Health and Community Services acquisition
Revenue
$589.23M
▲ 5.2% YoY Diluted EPS
$4.24
▲ 18.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Chemed Corp Q4 FY2023 Earnings Call
Positive tone
VITAS operational improvement and ADC growth
2024 guidance and margin outlook
Medicare reimbursement dynamics
Revenue
$585.91M*
▲ 7.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Chemed Corp Q3 FY2023 Earnings Call
Revenue
$564.53M
▲ 7.2% YoY Diluted EPS
$4.93
▲ 30.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Chemed Corp Q2 FY2023 Earnings Call
Revenue
$553.82M
▲ 4.2% YoY Diluted EPS
$3.51
▼ 20.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Chemed Corp Q1 FY2023 Earnings Call
Revenue
$560.16M
▲ 5.6% YoY Diluted EPS
$3.58
▼ 15.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Chemed Corp Q4 FY2022 Earnings Call
Revenue
$546.65M*
▲ 1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-31
Chemed Corp Q3 FY2022 Earnings Call
Revenue
$526.47M
▼ 2.3% YoY Diluted EPS
$3.78
▼ 16.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
Chemed Corp Q2 FY2022 Earnings Call
Revenue
$531.29M
▼ 0.2% YoY Diluted EPS
$4.40
▲ 25.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-26
Chemed Corp Q1 FY2022 Earnings Call
Revenue
$530.55M
▲ 0.6% YoY Diluted EPS
$4.22
▲ 5.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Chemed Corp Q4 FY2021 Earnings Call
Revenue
$540.98M*
▲ 1.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Chemed Corp Q3 FY2021 Earnings Call
Revenue
$538.67M
▲ 2% YoY Diluted EPS
$4.55
▲ 9.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Chemed Corp Q2 FY2021 Earnings Call
Revenue
$532.26M
▲ 6% YoY Diluted EPS
$3.51
▼ 29.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-27
Chemed Corp Q1 FY2021 Earnings Call
Revenue
$527.36M
▲ 2.2% YoY Diluted EPS
$4.01
▲ 18.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Chemed Corp Q4 FY2020 Earnings Call
Revenue
$533.29M*
▲ 2.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Chemed Corp Q3 FY2020 Earnings Call
Revenue
$528.30M
▲ 9.9% YoY Diluted EPS
$4.14
▲ 16.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Chemed Corp Q2 FY2020 Earnings Call
Revenue
$502.20M
▲ 6% YoY Diluted EPS
$5.01
▲ 62.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Chemed Corp Q1 FY2020 Earnings Call
Revenue
$515.80M
▲ 11.6% YoY Diluted EPS
$3.38
▲ 25.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-18
Chemed Corp Q4 FY2019 Earnings Call
Revenue
$522.32M*
▲ 14.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
19584
CUSIP
16359R103
13F (30d)
499 filings
472 filers
Visit website
Investor relations